99,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
50 °P sammeln
  • Broschiertes Buch

This book provides a wealth of insights, advances and new perspectives on cell therapy for different types of neonatal ischemic disease, such as Hypoxic-Ischemic Encephalopathy (HIE), Periventricular Leukomalacia (PVL) and neonatal infarction.
These diseases pose serious challenges for neonatologists and neurologists, because the severe sequelae lead to decreasing QOL for patients and their families. Accordingly, new treatments for neonatal ischemic diseases are needed all over the world.
The book develops new effective therapies combined with hypothermia therapy, an established
…mehr

Produktbeschreibung
This book provides a wealth of insights, advances and new perspectives on cell therapy for different types of neonatal ischemic disease, such as Hypoxic-Ischemic Encephalopathy (HIE), Periventricular Leukomalacia (PVL) and neonatal infarction.

These diseases pose serious challenges for neonatologists and neurologists, because the severe sequelae lead to decreasing QOL for patients and their families. Accordingly, new treatments for neonatal ischemic diseases are needed all over the world.

The book develops new effective therapies combined with hypothermia therapy, an established treatment for HIE. After reviewing past approaches, it presents cutting-edge topics in cell therapy, one of the most promising candidates for treating neonatal ischemic disease. Cell Therapy for Neonatal Ischemic Disease will offer readers a better understanding of the current state of the art in this field from bench to bedside, and inspire researchers and physicians to furtherexplore this evolving therapy.
Autorenporträt
Haruo ShintakuDepartment of Pediatrics,Osaka City University Graduate School of Medicine,OsakaJapan Akira OkaDepartment of Pediatrics,University of Tokyo, TokyoJapan Makoto Nabetani, Department of Pediatrics,Yodogawa Christian Hospital, Osaka,Japan
Rezensionen
"This book reviews advances the evolving cell therapy for various neonatal ischemic diseases. It has 14 chapters, with tables, illustrations and many references. For pediatric neonatologists, hematologists and researchers in biology." (Pediatric Endocrinology Reviews (PER), Vol. 16 (1), September, 2018)

"The book is aimed mostly at researchers, especially those involved in stem cell therapy. However, neonatologists and pediatric neurologists will find the concepts intriguing and sometimes exciting. The authors seem to be well regarded in this field. ... This is a provocative monograph that certainly could inform discussions on this cutting-edge therapy. ... For those curious about this novel therapy, this is an interesting read." (Jay P. Goldsmith, Doody's Book Reviews, May, 2018)